Matthias Leisegang
8PUBLICATIONS
45CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Oct 16, 2025
A CD22-specific T-cell receptor enables effective adoptive T-cell therapy for B-cell malignancies.Simone Rhein, Neşe Çakmak-Görür, Corinna Grunert
|May 02, 2025
Selection of therapeutically effective T-cell receptors from the diverse tumor-bearing repertoire.Leonie Rosenberger, Leo Hansmann, Vasiliki Anastasopoulou
|Sep 13, 2024
CD4+ T cells with convergent TCR recombination reprogram stroma and halt tumor progression in adoptive therapy.Steven P Wolf, Matthias Leisegang, Madeline Steiner
|Jan 26, 2024
Virus-reactive T cells expanded in aplastic anemia eliminate hematopoietic progenitor cells by molecular mimicry.Amin Ben Hamza, Carlotta Welters, Serena Stadler
|Jan 08, 2024
One CD4+TCR and One CD8+TCR Targeting Autochthonous Neoantigens Are Essential and Sufficient for Tumor Eradication.Steven P Wolf, Vasiliki Anastasopoulou, Kimberley Drousch
|Aug 22, 2023
A systematic safety pipeline for selection of T-cell receptors to enter clinical use.Zsofia Foldvari, Cathrine Knetter, Weiwen Yang
Pageof 2
Frequent Collaborators
3 joint publications
Steven P Wolf
2 joint publications
Jun Huang
2 joint publications
Erlend Strønen
2 joint publications
Hans Schreiber
2 joint publications
Karin Schreiber
2 joint publications
Kazuma Kiyotani
2 joint publications
Johanna Olweus
1 joint publications
Antonia Busse
1 joint publications
Josephine Kemna
1 joint publications
Marieke Griffioen
